Skip to main content

MJFF Publications

261 - 270 of 7665 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • RESTRICTED
    Title: Different impulse control disorder evolution patterns and white matter microstructural damage in the progression of Parkinson’s disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2023.1260630
    Citation Count: 0
  • RESTRICTED
    Title: Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1126/science.adi9926
    Best OA location URL:
    Citation Count: 10
  • RESTRICTED
    Title: Targeting Rab‐RILPL interactions as a strategy to downregulate pathogenic LRRK2 in Parkinson's disease
    Journal Name: Journal of Peptide Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/psc.3563
    Citation Count: 0
  • RESTRICTED
    Title: Biallelic BORCS8 variants cause an infantile-onset neurodegenerative disorder with altered lysosome dynamics
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: public-domain, public-domain
    DOI - Digital Object Identifier: 10.1093/brain/awad427
    Citation Count: 1
  • RESTRICTED
    Title: Comparison of state-of-the-art deep learning architectures for detection of freezing of gait in Parkinson’s disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2023.1306129
    Citation Count: 0
  • RESTRICTED
    Title: Multiomics analysis identifies novel facilitators of human dopaminergic neuron differentiation
    Journal Name: EMBO Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s44319-023-00024-2
    Best OA location URL:
    Citation Count: 1
  • RESTRICTED
    Title: NEMO reshapes the α-Synuclein aggregate interface and acts as an autophagy adapter by co-condensation with p62
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-44033-0
    Citation Count: 2
  • RESTRICTED
    Title: Association of cardiovascular disease management drugs with Lewy body dementia: a case–control study
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1093/braincomms/fcad346
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: PAK6-mediated phosphorylation of PPP2R2C regulates LRRK2-PP2A complex formation
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2023.1269387
    Citation Count: 0
  • RESTRICTED
    Title: scNAT: a deep learning method for integrating paired single-cell RNA and T cell receptor sequencing profiles
    Journal Name: Genome Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s13059-023-03129-y
    Citation Count: 1
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.